For the Inventor, By the Inventor

Enter assignee name

Oceanside, CA, United States of America

International Stem Cell Corporation

USPTO Granted Patents = 15

% Expired Patents = 33.3

CIPO Patents = 2

EPO Patents = 6

Trademarks = 1

Forward Citations = 21

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

Jeffrey D Janus (8 out of 9 patents)

Rodolfo Gonzalez (7 out of 7 patents)

Russell A Kern (5 out of 6 patents)

4. Elena S Revazova (4 out of 4 patents)

5. Leonid N Kuzmichev (4 out of 4 patents)

6. Ibon Garitaonandia (4 out of 4 patents)

7. Marina V Pryzhkova (3 out of 3 patents)

8. Nikolay Turovets (2 out of 9 patents)

9. Maxim Poustovoitov (2 out of 2 patents)

10. Ruslan Semechkin (2 out of 2 patents)

11. Larisa Agapova (2 out of 2 patents)

12. Andrey Semechkin (2 out of 3 patents)

13. Nickolay A Turovets (1 out of 1 patent)

14. Judy Kelleher-Andersson (0 patent)

15. Jeremy Hammond (0 patent)

15 patents: Sort by Forward Citations

1. 11324778 - Parthenogenic activation of human oocytes for the production of neuronal cells (2022-05-10),

2. 11007232 - Use of neural cells derived from human pluripotent stem cells for the treatment of neurodegenerative diseases (2021-05-18),

3. 10457915 - Chemical differentiation of pluripotentstem cells into retinal epithelial cells (2019-10-29),

4. 10335422 - Small molecules that promote skin regeneration (2019-07-02),

5. 10258632 - Method of prevention of neurological diseases (2019-04-16),

6. 10039794 - Use of neural cells derived from human pluripotent stem cells for the treatment of neurodegenerative diseases (2018-08-07),

7. 9926529 - Derivation of neural stem cells and dopaminergic neurons from human pluripotent stem cells (2018-03-27),

8. 9920299 - Patient-specific stem cell lines derived from human parthenogenetic blastocysts (2018-03-20),

9. 9375439 - Small molecules that promote skin regeneration (2016-06-28),

10. 8986995 - Methods of deriving differentiated cells from stem cells (2015-03-24),

11. 8945083 - Cell culture medium container assembly (2015-02-03),

12. 8420393 - Generation of an autologous stem cell library from human oocytes parthenogenetically activated by high or low oxygen tension (2013-04-16),

13. 8268621 - Methods of deriving definitive endoderm cells from pluripotent parthenogenetic stem cells (2012-09-18),

14. 7935100 - Cell culture medium container assembly (2011-05-03),

15. 7732202 - Oxygen tension for the parthenogenic activation of human oocytes for the production of human embryonic stem cells (2010-06-08),

International Stem Cell Corporation, based in Oceanside, California, is a biotechnology company focused on developing innovative stem cell-based therapies and products. The organization specializes in human stem cell research and regenerative medicine, aiming to address various medical conditions through its proprietary technologies. By leveraging its expertise in stem cell biology, the company seeks to advance therapeutic solutions and contribute to the growing field of regenerative medicine, with potential applications in numerous healthcare sectors.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

15 Patents

#10 in Oceanside, CA

#5,022 in California

#21,034 in US

#39,881 in the World

Oceanside, CA, United States of America

International Stem Cell Corporation

Forward Citations = 21

13 inventors:

Jeffrey D Janus (8 out of 9 patents)

Rodolfo Gonzalez (7 out of 7 patents)

Russell A Kern (5 out of 6 patents)

4. Elena S Revazova (4 out of 4 patents)

5. Leonid N Kuzmichev (4 out of 4 patents)

Please report any incorrect information to [email protected]

Loading…